Week of April 4, 2023 | Vol. 12, Issue 13

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

TRADING COMPS

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and portfolio

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Neopharm Labs Acquires MS Pharma

Contract Pharma - Mar 27, 2023

CVS closed $8B deal for health services company Signify Health

Fierce Biotech - Mar 29, 2023

Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies

Business Wire - Mar 29, 2023

Piramal Pharma Solutions Supports TheracosBio’s Bexagliflozin Program

Contract Pharma - Mar 29, 2023

BeVinced debuts as CRO focused on medical device services

Fierce Biotech - Mar 29, 2023

Catalent Launches New Oral Developability Assessment and Manufacturing Solution to Advance Targeted Protein Degrader Programs

Catalent - Mar 29, 2023

Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program

PR Newswire - Mar 30, 2023

Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™

Business Wire - Mar 30, 2023

Galapagos, following Sanofi's playbook, offloads French R&D site to drug discovery CRO

Fierce Biotech - Mar 31, 2023

TANNER NEWS

Tanner Pharma Group to Distribute an Innovative Product that Protects & Repairs the Gastrointestinal Mucosa

We’re pleased to announce our partnership with Azienda Farmaceutica Italiana srl. TannerLAC will be responsible for the registration, commercialization and promotion of AFI’s novel product Hepilor® in Latin America. Read more here.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.